Researchers at National Jewish Health have found that a subset of children suffering recurring fevers as a result of long COVID-19 have benefited from a daily medication treatment commonly used for gout and periodic fever ...
Apr 25, 2023
0
59
Researchers at National Jewish Health have identified an immune and lipid profile on the surface of the skin of infants that can predict the development of atopic dermatitis, or eczema, months before the onset of clinical ...
Feb 23, 2023
0
22
Researchers at National Jewish Health have published data that will help medical providers better understand the susceptibility of various nontuberculous mycobacteria (NTM) to different drugs. This new antibiogram will assist ...
Feb 15, 2023
0
14
Researchers at National Jewish Health have shown that vapor from electronic cigarettes increases small airway inflammation response to influenza A infections. The findings show that short-term exposure of just three days ...
Nov 14, 2022
0
11
Researchers have shown that the medication saracatinib shows promise as a treatment for idiopathic pulmonary fibrosis (IPF). Saracatinib worked as well or better than two approved drugs at reducing tissue scarring in preclinical ...
Oct 13, 2022
1
37
A National Jewish Health led study finds that children who develop shortness of breath after COVID-19 infection have evidence of peripheral airway obstruction. These children can experience persistent fatigue, shortness of ...
Sep 29, 2022
0
25
For the first time, researchers have shown that a class of anti-fibrotic drugs slows the progression of interstitial lung disease (ILD) in patients with rheumatoid arthritis (RA). Research conducted in part at National Jewish ...
Sep 22, 2022
0
21
A National Jewish Health led study recently published in Lupus finds that technology using video game-based cognitive therapy improves attention and executive functioning in patients with systemic lupus erythematosus (SLE).
Jul 14, 2022
0
2
While cancer patients and their doctors focus on eradicating their disease, there is often another life-threatening health issue developing throughout the course of treatment. Cancer therapies such as chemotherapy, radiation ...
Jun 27, 2022
0
8
More than a fifth of patients with chronic medical conditions may still have insufficient levels of antibodies to fight COVID-19 even after a second mRNA vaccine dose. Both the Pfizer and the Moderna vaccines are mRNA vaccines. ...
Jan 17, 2022
0
18
